NMTC Neuroone Medical Technologies Corp
Company Analysis
Latest News
🟢 Neuroone Medical Technologies is trading 19.68% up today amid broad healthcare-sector rally
Neuroone Medical Technologies is trading 19.68% up now at $2.25 amid a broad healthcare-sector rally, with Healthcare (XLV) up 3.23% during regular trading. -...
🟢 Neuroone Medical Technologies is trading 11.16% up today as healthcare gains 1.59%
Neuroone Medical Technologies is trading 11.16% up at $2.09, outperforming a weaker broad market as healthcare gains 1.59%. - No new company-specific...
🟢 Neuroone Medical Technologies is trading 8.51% up today amid a healthcare-sector rally
Neuroone Medical Technologies is trading 8.51% up at $2.04 amid a healthcare-sector rally while major technology indexes decline. - No new company-specific...
NeuroOne's Orders Surge 43% and Margins Hit Records, but Can a Small Medtech Company Ship Its Way Out of a Manufacturing Bottleneck?
Shares of NeuroOne Medical Technologies jumped 10.4% to $2.02 on August 13 after the company's fiscal third-quarter earnings revealed a paradox investors...
🟢 Neuroone Medical Technologies is trading 10.38% up today after earnings showed record gross margin
Neuroone Medical Technologies is trading 10.38% up at $2.02 after its August 13, 2026 fiscal third-quarter earnings report highlighted record gross margin. -...
🟢 Neuroone Medical Technologies is trading 6.25% up today after orders climbed 43% and backlog hit record
Neuroone Medical Technologies is trading at $1.94 (+6.25%) after new orders climbed 43% and gross margin expanded to 59.9%. - Fiscal third-quarter product...
🔴 Neuroone Medical Technologies is trading 5% down in pre-market after revenue miss and lowered outlook
Neuroone Medical Technologies is trading 5.11% down now at $1.44 after fiscal third-quarter product revenue missed estimates and management lowered its fiscal...
NeuroOne's third quarter revenue of $2.0M missed expectations as company lowered fiscal year 2026 guidance
NeuroOne reported third quarter fiscal 2026 product revenue of $1.97 million, a 16% year-over-year increase that fell short of the $2.5 million analyst...
Neuroone Medical Technologies Corp Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
For the fiscal quarter ending June 30, 2026, Neuroone Medical Technologies is expected to report a consensus loss of $0.22 per share on revenue of $2.5...
🟢 Neuroone Medical Technologies is trading 6.4% up today after ISO 13485-2016 certification
Neuroone Medical Technologies is trading 6.4% up at $1.66 after announcing ISO 13485-2016 certification on August 11, 2026. - The milestone supports...
🔴 Neuroone Medical Technologies is trading 6.45% down today with no company-specific explanation identified
Neuroone Medical Technologies is trading 6.45% down at $1.52, with no company-specific announcement identified to explain the August 10, 2026 decline. - The...
NeuroOne Surges on Mayo Clinic Epilepsy Data, but Can a $1.93 Stock Sustain Momentum Without Revenue to Back It Up?
Shares of NeuroOne Medical Technologies jumped 13.5% to $1.93 on Thursday, extending a rally fueled by real-world clinical evidence from Mayo Clinic showing...
🔴 Neuroone Medical Technologies is trading 6.06% down today as the immediate cause remains uncertain
Neuroone Medical Technologies is trading 6.06% down now at $1.55, with the immediate cause uncertain. - No clear company-specific announcement or filing...
🟢 Neuroone Medical Technologies Corp is trading 6.51% up in pre-market
NMTC is trading at $1.80, up 6.51% in pre-market.
🟢 Neuroone Medical Technologies is trading 9.3% up today on positive Mayo Clinic data for its OneRF system
Neuroone Medical Technologies is trading at $1.85 (9.3% up) in after-hours trading as investors react to positive Mayo Clinic physician experience data for its...
🟢 Neuroone Medical Technologies is trading 14% up today on positive Mayo Clinic data for its OneRF epilepsy ablation system
Neuroone Medical Technologies is trading 14% up now at $1.93, extending gains following positive physician experience data from a Mayo Clinic study of epilepsy...
🟢 Neuroone Medical Technologies is trading 6.5% up today on follow-through from positive Mayo Clinic study data
Neuroone Medical Technologies is trading 6.5% up at $1.80 following strong follow-through from physician-reported outcomes in a Mayo Clinic study of its brain...
🟢 Neuroone Medical Technologies is trading 5.9% up today after positive Mayo Clinic study data
Neuroone Medical Technologies is trading at $1.80 (5.9% up) after positive physician-reported outcomes from a Mayo Clinic study evaluating the company’s brain...
🟢 Neuroone Medical Technologies jumps 5.9% in after-hours trading on positive Mayo Clinic epilepsy data
Neuroone Medical Technologies closed at $1.70 (+3.03%) on July 30, and extended its rally in after-hours trading to $1.80 (+5.88% from today's close). • The...
NeuroOne's Mayo Clinic Epilepsy Data Lifts Shares 8% — But Can a $15 Million Micro-Cap Survive Long Enough to Capitalize?
Shares of NeuroOne Medical Technologies surged 8.3% to $1.79 on July 30, bucking a weak healthcare tape, after investors seized on positive physician feedback...